ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
21.98
+0.64 (3.00%)
At close: Jun 6, 2025, 4:00 PM
21.75
-0.23 (-1.05%)
After-hours: Jun 6, 2025, 5:06 PM EDT

ACADIA Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
3,6793,0535,1402,5783,7528,499
Upgrade
Market Cap Growth
-9.07%-40.60%99.40%-31.29%-55.85%28.98%
Upgrade
Enterprise Value
3,0532,5374,8522,2043,2787,904
Upgrade
Last Close Price
21.9818.3531.3115.9223.3453.46
Upgrade
PE Ratio
16.0613.48----
Upgrade
Forward PE
46.3735.9027.40---
Upgrade
PS Ratio
3.673.197.084.987.7519.24
Upgrade
PB Ratio
4.804.1711.916.446.9413.56
Upgrade
P/TBV Ratio
5.684.9814.046.446.9413.58
Upgrade
P/FCF Ratio
24.7819.42308.70---
Upgrade
P/OCF Ratio
24.6919.36307.78---
Upgrade
EV/Sales Ratio
3.062.656.684.266.7717.89
Upgrade
EV/EBITDA Ratio
30.0325.33----
Upgrade
EV/EBIT Ratio
34.5530.11----
Upgrade
EV/FCF Ratio
20.5716.14291.36---
Upgrade
Debt / Equity Ratio
0.070.070.130.160.120.08
Upgrade
Debt / EBITDA Ratio
0.500.47----
Upgrade
Debt / FCF Ratio
0.380.333.44---
Upgrade
Asset Turnover
1.000.991.090.800.650.56
Upgrade
Inventory Turnover
9.4513.3318.5351.2229.4435.81
Upgrade
Quick Ratio
2.632.182.133.826.106.44
Upgrade
Current Ratio
2.882.382.424.046.436.77
Upgrade
Return on Equity (ROE)
37.24%38.89%-14.73%-45.89%-28.75%-42.47%
Upgrade
Return on Assets (ROA)
5.56%5.44%-6.86%-21.70%-14.37%-18.66%
Upgrade
Return on Capital (ROIC)
8.21%8.27%-9.64%-26.18%-16.62%-21.09%
Upgrade
Return on Capital Employed (ROCE)
10.60%10.60%----
Upgrade
Earnings Yield
6.22%7.42%-1.19%-8.38%-4.47%-3.31%
Upgrade
FCF Yield
4.04%5.15%0.32%-4.42%-3.38%-1.69%
Upgrade
Buyback Yield / Dilution
-1.32%-1.55%-1.32%-0.74%-2.01%-6.88%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q